- Home
- SNOW vs REGN Comparison
SNOW vs REGN Comparison
Compare SNOW & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOW
- REGN
- Stock Information
- Founded
- SNOW 2012
- REGN 1988
- Country
- SNOW United States
- REGN United States
- Employees
- SNOW N/A
- REGN N/A
- Industry
- SNOW Computer Software: Prepackaged Software
- REGN Biotechnology: Pharmaceutical Preparations
- Sector
- SNOW Technology
- REGN Health Care
- Exchange
- SNOW Nasdaq
- REGN Nasdaq
- Market Cap
- SNOW 73.2B
- REGN 59.5B
- IPO Year
- SNOW 2020
- REGN 1991
- Fundamental
- Price
- SNOW $262.55
- REGN $656.00
- Analyst Decision
- SNOW Strong Buy
- REGN Buy
- Analyst Count
- SNOW 44
- REGN 21
- Target Price
- SNOW $253.26
- REGN $782.62
- AVG Volume (30 Days)
- SNOW 4.1M
- REGN 990.2K
- Earning Date
- SNOW 12-03-2025
- REGN 10-28-2025
- Dividend Yield
- SNOW N/A
- REGN 0.54%
- EPS Growth
- SNOW N/A
- REGN 2.88
- EPS
- SNOW N/A
- REGN 41.59
- Revenue
- SNOW $4,115,907,000.00
- REGN $14,247,800,000.00
- Revenue This Year
- SNOW $29.52
- REGN $1.34
- Revenue Next Year
- SNOW $23.61
- REGN $5.23
- P/E Ratio
- SNOW N/A
- REGN $15.81
- Revenue Growth
- SNOW 28.36
- REGN 2.89
- 52 Week Low
- SNOW $119.66
- REGN $476.49
- 52 Week High
- SNOW $280.67
- REGN $834.42
- Technical
- Relative Strength Index (RSI)
- SNOW 58.51
- REGN 68.06
- Support Level
- SNOW $262.61
- REGN $625.14
- Resistance Level
- SNOW $274.35
- REGN $657.00
- Average True Range (ATR)
- SNOW 9.08
- REGN 18.08
- MACD
- SNOW -0.68
- REGN 4.38
- Stochastic Oscillator
- SNOW 57.26
- REGN 91.23
About SNOW Snowflake Inc.
Founded in 2012, Snowflake is a fully managed platform that consolidates data hosted on different public clouds for centralized analytics and governance. Snowflake's cloud-native architecture allows users to independently scale the compute and storage layers, providing customers with optimized performance at lower costs. The company's data lake and data warehouse products support a variety of use cases, including business analytics, data engineering, and artificial intelligence. Snowflake is widely used by Fortune 2000 companies in financial services, media, and retail sectors.
About REGN Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).